Home Biogen Idec wins Canadian approval for hemophilia drug Alprolix
 

Keywords :   


Biogen Idec wins Canadian approval for hemophilia drug Alprolix

2014-03-21 15:39:52| Biotech - Topix.net

Hemophilia B, a rare inherited disorder in which the ability of a person's blood to clot is impaired, affects some 4,000 people in the United States and roughly 25,000 worldwide.

Tags: drug approval canadian wins

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
07.10Perfect storm blocking thousands of desperately needed social homes
07.10Hurricane Milton Public Advisory Number 6A
07.10Summary for Hurricane Milton (AT4/AL142024)
07.10Atlantic Tropical Weather Outlook
07.10Eastern North Pacific Tropical Weather Outlook
07.10Can selling off homes for $1 solve urban blight?
06.10Hurricane Milton Potential Storm Surge Flooding Map
06.10Hurricane Milton Probabilistic Storm Surge Graphics
More »